Sleep apnea is a sleep disorder where the breathing repeatedly stops and starts during sleep. This happens when someone wakes ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

An international and widely supported group of experts is pushing doctors to avoid the exclusive use of BMI to decide whether ...

Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...

Eli Lilly CEO confirms oral obesity drug Phase 3 results expected in Q2 Eli Lillys CEO updates on drug trials amid mixed ...

As of March 2020, nearly 42% of US adults had obesity, with the report estimating that more than a billion people are living ...

Get real-time updates on health from celebrity fitness secrets and weight loss breakthroughs to nutrition advice, get your ...

With the increasing prevalence of sleep apnea, driven by factors like obesity and aging populations, there is growing demand for these diagnostic solutions. The development of non-invasive ...

Researchers have redefined obesity, emphasizing the impact of excess adiposity on organ and tissue function rather than ...